Literature DB >> 31949051

VISTA is a checkpoint regulator for naïve T cell quiescence and peripheral tolerance.

Mohamed A ElTanbouly1, Yanding Zhao2,3, Elizabeth Nowak1, Jiannan Li4, Evelien Schaafsma2,3, Isabelle Le Mercier5, Sabrina Ceeraz6, J Louise Lines1, Changwei Peng7,8, Catherine Carriere9, Xin Huang9, Maria Day9, Brent Koehn10, Sam W Lee11, Milagros Silva Morales7, Kristin A Hogquist7,8, Stephen C Jameson7,8, Daniel Mueller7,8, Jay Rothstein9, Bruce R Blazar10,12, Chao Cheng13,14, Randolph J Noelle15,9.   

Abstract

Negative checkpoint regulators (NCRs) temper the T cell immune response to self-antigens and limit the development of autoimmunity. Unlike all other NCRs that are expressed on activated T lymphocytes, V-type immunoglobulin domain-containing suppressor of T cell activation (VISTA) is expressed on naïve T cells. We report an unexpected heterogeneity within the naïve T cell compartment in mice, where loss of VISTA disrupted the major quiescent naïve T cell subset and enhanced self-reactivity. Agonistic VISTA engagement increased T cell tolerance by promoting antigen-induced peripheral T cell deletion. Although a critical player in naïve T cell homeostasis, the ability of VISTA to restrain naïve T cell responses was lost under inflammatory conditions. VISTA is therefore a distinctive NCR of naïve T cells that is critical for steady-state maintenance of quiescence and peripheral tolerance.
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31949051      PMCID: PMC7391053          DOI: 10.1126/science.aay0524

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   63.714


  91 in total

1.  Dietary antigens limit mucosal immunity by inducing regulatory T cells in the small intestine.

Authors:  Kwang Soon Kim; Sung-Wook Hong; Daehee Han; Jaeu Yi; Jisun Jung; Bo-Gie Yang; Jun Young Lee; Minji Lee; Charles D Surh
Journal:  Science       Date:  2016-01-28       Impact factor: 47.728

Review 2.  Differentiation of effector CD4 T cell populations (*).

Authors:  Jinfang Zhu; Hidehiro Yamane; William E Paul
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

3.  Deficient positive selection of CD4 T cells in mice displaying altered repertoires of MHC class II-bound self-peptides.

Authors:  C E Grubin; S Kovats; P deRoos; A Y Rudensky
Journal:  Immunity       Date:  1997-08       Impact factor: 31.745

4.  LKLF: A transcriptional regulator of single-positive T cell quiescence and survival.

Authors:  C T Kuo; M L Veselits; J M Leiden
Journal:  Science       Date:  1997-09-26       Impact factor: 47.728

5.  Autocrine IFN-γ promotes naive CD8 T cell differentiation and synergizes with IFN-α to stimulate strong function.

Authors:  Julie M Curtsinger; Pujya Agarwal; Debra C Lins; Matthew F Mescher
Journal:  J Immunol       Date:  2012-06-15       Impact factor: 5.422

Review 6.  Autoreactive T cells in murine lupus: origins and roles in autoantibody production.

Authors:  J Craft; S Peng; T Fujii; M Okada; S Fatenejad
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

7.  BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes.

Authors:  Philippe Bouillet; Jared F Purton; Dale I Godfrey; Li-Chen Zhang; Leigh Coultas; Hamsa Puthalakath; Marc Pellegrini; Suzanne Cory; Jerry M Adams; Andreas Strasser
Journal:  Nature       Date:  2002-02-21       Impact factor: 49.962

8.  Cicero Predicts cis-Regulatory DNA Interactions from Single-Cell Chromatin Accessibility Data.

Authors:  Hannah A Pliner; Jonathan S Packer; José L McFaline-Figueroa; Darren A Cusanovich; Riza M Daza; Delasa Aghamirzaie; Sanjay Srivatsan; Xiaojie Qiu; Dana Jackson; Anna Minkina; Andrew C Adey; Frank J Steemers; Jay Shendure; Cole Trapnell
Journal:  Mol Cell       Date:  2018-08-02       Impact factor: 17.970

9.  Control of signaling-mediated clearance of apoptotic cells by the tumor suppressor p53.

Authors:  Kyoung Wan Yoon; Sanguine Byun; Eunjeong Kwon; So-Young Hwang; Kiki Chu; Masatsugu Hiraki; Seung-Hee Jo; Astrid Weins; Samy Hakroush; Angelika Cebulla; David B Sykes; Anna Greka; Peter Mundel; David E Fisher; Anna Mandinova; Sam W Lee
Journal:  Science       Date:  2015-07-31       Impact factor: 47.728

10.  Effects of in vivo administration of anti-T3 monoclonal antibody on T cell function in mice. I. Immunosuppression of transplantation responses.

Authors:  R Hirsch; M Eckhaus; H Auchincloss; D H Sachs; J A Bluestone
Journal:  J Immunol       Date:  1988-06-01       Impact factor: 5.422

View more
  46 in total

Review 1.  Cellular Mechanisms and Regulation of Quiescence.

Authors:  Océane Marescal; Iain M Cheeseman
Journal:  Dev Cell       Date:  2020-11-09       Impact factor: 12.270

Review 2.  Rethinking peripheral T cell tolerance: checkpoints across a T cell's journey.

Authors:  Mohamed A ElTanbouly; Randolph J Noelle
Journal:  Nat Rev Immunol       Date:  2020-10-19       Impact factor: 53.106

Review 3.  Tumor microenvironmental influences on dendritic cell and T cell function: A focus on clinically relevant immunologic and metabolic checkpoints.

Authors:  Kristian M Hargadon
Journal:  Clin Transl Med       Date:  2020-01

Review 4.  VISTA: Coming of age as a multi-lineage immune checkpoint.

Authors:  M A ElTanbouly; E Schaafsma; R J Noelle; J L Lines
Journal:  Clin Exp Immunol       Date:  2020-02-04       Impact factor: 4.330

Review 5.  Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts.

Authors:  Yuchen Wang; Hao Zhang; Chao Liu; Zeyu Wang; Wantao Wu; Nan Zhang; Longbo Zhang; Jason Hu; Peng Luo; Jian Zhang; Zaoqu Liu; Yun Peng; Zhixiong Liu; Lanhua Tang; Quan Cheng
Journal:  J Hematol Oncol       Date:  2022-08-17       Impact factor: 23.168

Review 6.  IGSF11 and VISTA: a pair of promising immune checkpoints in tumor immunotherapy.

Authors:  Xi-Yang Tang; Yan-Lu Xiong; Xian-Gui Shi; Ya-Bo Zhao; An-Ping Shi; Kai-Fu Zheng; Yu-Jian Liu; Tao Jiang; Nan Ma; Jin-Bo Zhao
Journal:  Biomark Res       Date:  2022-07-13

7.  VISTA is an activating receptor in human monocytes.

Authors:  Bryan M Rogers; Laura Smith; Zoltan Dezso; Xu Shi; Enrico DiGiammarino; Denny Nguyen; Sunantha Sethuraman; Pingping Zheng; Donghee Choi; Dong Zhang; Andrew Nguyen; Kathleen McGuire; Wei Liu; Namjin Chung; Debra T Chao; Shiming Ye; Gabriel R Starbeck-Miller
Journal:  J Exp Med       Date:  2021-06-09       Impact factor: 14.307

8.  VISTA regulates microglia homeostasis and myelin phagocytosis, and is associated with MS lesion pathology.

Authors:  Malte Borggrewe; Susanne M Kooistra; Evelyn M Wesseling; Fenja L Gierschek; Maaike L Brummer; Elizabeth C Nowak; Tiago Medeiros-Furquim; Tegan A Otto; Sam W Lee; Randolph J Noelle; Bart J L Eggen; Jon D Laman
Journal:  Acta Neuropathol Commun       Date:  2021-05-18       Impact factor: 7.801

Review 9.  The Role of V-Domain Ig Suppressor of T Cell Activation (VISTA) in Cancer Therapy: Lessons Learned and the Road Ahead.

Authors:  Negar Hosseinkhani; Afshin Derakhshani; Mahdi Abdoli Shadbad; Antonella Argentiero; Vito Racanelli; Tohid Kazemi; Ahad Mokhtarzadeh; Oronzo Brunetti; Nicola Silvestris; Behzad Baradaran
Journal:  Front Immunol       Date:  2021-05-19       Impact factor: 7.561

10.  Investigation of Genetic Determinants of Glioma Immune Phenotype by Integrative Immunogenomic Scale Analysis.

Authors:  Binghao Zhao; Yuekun Wang; Yaning Wang; Congxin Dai; Yu Wang; Wenbin Ma
Journal:  Front Immunol       Date:  2021-06-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.